Does MEPOLIZUMAB Cause Hyperventilation? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Hyperventilation have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.2% of all adverse event reports for MEPOLIZUMAB.
70
Reports of Hyperventilation with MEPOLIZUMAB
0.2%
of all MEPOLIZUMAB reports
1
Deaths
46
Hospitalizations
How Dangerous Is Hyperventilation From MEPOLIZUMAB?
Of the 70 reports, 1 (1.4%) resulted in death, 46 (65.7%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Hyperventilation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Hyperventilation?
OMALIZUMAB (112)
ALBUTEROL (108)
METFORMIN (88)
CARBIDOPA\LEVODOPA (84)
PREDNISONE (77)
ADALIMUMAB (75)
ASPIRIN (75)
IBUPROFEN (73)
DULOXETINE (70)
BUDESONIDE\FORMOTEROL (66)
Which MEPOLIZUMAB Alternatives Have Lower Hyperventilation Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE